Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV Vaccine (GSK1674330A) in Healthy Female Subjects Aged 18-25 Years.

NCT00478621 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00478621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00478621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV Vaccine (GSK1674330A) in Healthy Female Subjects Aged 18-25 Years.
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Completed
Start date
May 25, 2007
Completion date
October 13, 2008
Enrollment
540 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus